Cite
APA Citation
Regueiro, M., Siegmund, B., Yarur, A., Steinwurz, F., Gecse, K. B., Goetsch, M., Bhattacharjee, A., Wu, J., Green, J., McDonnell, A., Crosby, C., Lazin, K., Ferreira Branquinho, D., Modesto, I., & Abreu, M. T. (n.d.). p558 Etrasimod for the treatment of ulcerative colitis: analysis of infection rates from the phase 3 ELEVATE UC 52 and ELEVATE UC 12 clinical trials. Journal of Crohn's and colitis, 17, i689–i690. http://access.bl.uk/ark:/81055/vdc_100179844173.0x000010